© 2024 Alpha Spread Limited. All Rights Reserved.
www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.
You don't have any saved screeners yet
Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.
Greetings and welcome to the Physicians Realty Trust Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Brad Page, SVP, General Counsel. Please go ahead.
Thank you. Good morning and welcome to the Physicians Realty Trust's first quarter 2023 earnings conference call and webcast. Joining me today are John Thomas, Chief Executive Officer; Jeff Theiler, Chief Financial Officer; Deeni Taylor, Chief Investment Officer; Mark Theine, Executive Vice President, Asset Management; John Lucey, Chief Accounting and Administrative Officer; Lori Becker, Senior Vice President, Controller.
During this call, John Thomas will provide a summary of the company's activities and performance for the first quarter of 2023 and our year-to-date performance as well as our strategic focus for the remainder of the year. Jeff Theiler will review our financial results for the first quarter of 2023, and Mark Theine will provide a summary of our operations for the first quarter.
Today's call will contain forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. They reflect view of management regarding current expectations and projections about future events and are based on information currently available to us.
These forward-looking statements are not guarantees of future performance and involve numerous risks and uncertainties. You should not rely on them as predictions of future events.
Our forward-looking statements depend on assumptions, data, and methods that may be incorrect or imprecise and we may not be able to realize them. We do not guarantee that transactions and events described will happen as described or that they will happen at all.
For more detailed description of risks and other important factors that could cause our actual results to differ from those contained in any forward-looking statements, please refer to our filings with the Securities and Exchange Commission.
With that, I would now like to turn the call over to the company's CEO, John Thomas, John?
Thank you, Brad. Physicians Realty Trust provides real estate capital to healthcare providers that specialize in outpatient medical services. We provide this capital in a number of ways. We acquire outpatient medical real estate designed to facilitate surgery, oncology, and other specialty services required by patients in high demand and the physician patient encounters ancillary to these medical services. We financed the development of these types of buildings.
And we finance the transformation of buildings that may have become out of date as is, but provide a low cost option for transforming to host these medical services and meet the demands of our growinG&Aging US population.
Our facilities and providers we partner with around the country provide accessed care for the entire population in the markets where we are located, not just the finite small percentage of seniors that can pay for and want senior housing.
For years, the fundamental case for owning outpatient medical facilities has been strong, but is now stronger than ever. First, healthcare providers benefit from undeniable demographic tailwinds currently and that will dramatically increase demand for services in both the near and long-term.
Second, due to Medicare's Progressive Payment System and Part C modernization, providers are incentivized to provide care at the lowest possible cost consistent with the clinical science available at the time to treat the patient safely and effectively.
Third, current expense pressures are temporary and correctable. These pressures are caused by the unique combination of real time inflation and backward looking payer revenue rates that are set based on past costs rather than current or future expected costs.
Each of these factors incentivizes health systems to move patients out of the inpatient hospital setting and into newer, lower cost outpatient sites of care as a means of improving their margin on services provided. These trends have been known and visible for years and have only accelerated in the post-COVID world.
Time and time again, buildings hosting outpatient medical services have proven to be resilient and an essential class of real estate. When one of our clients chooses to reduce their space at the end of their lease, is not due to a top -- it is not due to a desire to work from home, the result of slowing demand or a consequence of a rapid rise in interest rates.
Rather, our non-renewals are driven by unique and specific situations like physician retirements or a change in practice ownership. These are not structural trends or challenges. Our real estate is necessary for physicians and health systems to deliver their mission to meet ever increasing demand.
Unlike other real estate asset classes faced with declining demand for space. Revenue from outpatient medical services grew 8% in 2022, in comparison inpatient revenues experienced no growth. High construction costs and the limited supply growth have allowed us to meaningfully increase rental rates in most markets and we expect to see that trend continue.
The opportunity for new acquisition investments remains low for now as private investors make short-term wages on medical office cap rates returning to 2020 levels even at the cost of negative leverage.
We believe that patience is a virtue and we will benefit from outsized growth and acquisition opportunities with our dry powder when market cap rates and the long-term cost of capital reach equilibrium.
We do see a growing number of opportunities to finance new outpatient medical investments in our active pipeline in discussions now exceeds $300 million. We're proud of the two projects we started this past quarter, including our first on balance sheet development and expect to start several new projects later this year.
We're excited to share that we've executed contractual commitments related to a $40 million medical office development located in the high growth at Atlanta Server of Beaufort Georgia.
The 97,000 square foot outpatient medical facility, which includes an ambulatory surgery center, is 100% pre-leased on 10-year triple net lease terms with 91% leased directly to Northside Hospital, an investment-grade quality health system. The site also allows for an additional 100,000 square foot medical facility in the future, where we will have the development rights to build.
Northside Hospital and affiliated physicians have executed leases based on a 6.2% yield on cost to deliver the project with 3% risk escalators on all lease agreements. Physicians that lease space and provide services in the building have contributed 44 some of the capital to develop this building. This investment increases our long standing partnership with Northside Hospital and is a direct reflection of DOC's strong relationships with health systems, we want to work with a long-term partner who knows healthcare first.
Before our next earnings call, we will celebrate the 10th anniversary of an of our initial public offering. We appreciate your support, the support of all the families that work for and with DOC, and the investment-grade credit and high quality providers that partner with us meet the healthcare needs and the communities we serve.
We look forward to the next 10 years and beyond. We believe we have the highest occupancy, the best balance sheet, and the best strategy for outsized growth well into the next 10 years and beyond.
Quarter one was uneventful until we lost George Chapman, who passed away unexpectedly and well before his time. George made Healthcare REIT the powerhouse that it is today. I can't count the number of senior executives and professionals at public and private REITs and otherwise, that owe their careers to George's inspiration and mentorship. I can name at least three public REIT CEOs who are our stewards and direct beneficiaries of George's leadership.
But more important than all the financial and business success, George was motivated most by his love for his family, Toledo, The Art, Cornell [ph] and the University of Toledo and taking care of seniors in advancing access to healthcare services for all regardless of their ability to pay.
I believe George is looking down on all of us asking us how we are going to work to expand access to care to all, expanding senior housing to more, and providing professional opportunities to the youth of Toledo and everywhere to meet these objectives. George, we miss you . We at DOC are committed to your passion and mission.
Jeff will now share comments on our financial results of Q1 2023 and Mark will discuss our operating results. Jeff?
Thank you, John. In the first quarter of 2023, the company generated normalized funds from operations of $60.3 million or $0.24 per share. Our normalized funds available for distribution were $59.7 million, an increase of 3% over the comparable quarter of last year and our FAD per share was $0.24.
The portfolio showed consistent operations with same-store NOI across our entire MOB portfolio increasing at 1.0%. This is below our long-term expectations for the portfolio.
As we've discussed over the past two quarters, we anticipate this metric returning to our long-term expectations in the back half of the year as our repositioning properties start to roll back online.
Our renewal spreads for the full MOB portfolio were negative 0.7% as one renewal had an outsized effect on an otherwise strong period of lease. Despite this, we still anticipate averaging positive mid-single-digit leasing spreads over the entire year, in line with our previous guidance.
Across the portfolio, we continue to see evidence that our existing rents are under the current market rates, which allows for additional pricing power on new and renewal leases.
Additionally, the historic rise in construction costs and uncertainty in asset pricing have been significant hurdles for new medical office development. Which we believe will enhance our ability to retain tenants.
On the acquisitions front, we are starting to deploy capital, but in a careful manner. Our new investments have been concentrated on development projects with healthcare partners that have been in planning for multiple years.
Encouragingly, the acquisition pipeline that we are actively negotiating has picked up significantly since the beginning of the year. We believe this will enable us to generate accretive external growth in the second half of the year.
In order to reduce debt, existing debt and allow ourselves to be prepared for these future opportunities. We strengthened the balance sheet with $66 million of equity issued on the ATM in the beginning of the first quarter. We had previously disclosed this activity on our last earnings call. We feel that we are in an excellent position from a capital perspective at 5.3 times consolidated debt to EBITDA.
Finally, we remain on track for our overall G&A guidance. A quick reminder to our analysts and investors that our G&A is always seasonally higher in the first quarter and we expect it to moderate going forward.
With that, I'll turn it over to Mark to walk through some additional operational details. Mark?
Thanks Jeff. To best capitalize on the opportunity we have within our portfolio, we are occasionally better served by transitioning space from 1 physician organization to another. These decisions are made to improve the overall financial health and value of our buildings over the long-term, but generally have a short-term impact on our net operating income.
Among other benefits, these strategic efforts have served to dramatically improve the credit profile of our portfolio. This is especially relevant in today's environment where higher operating expenses are offsetting revenue gains for health systems.
DOC's portfolio remains well-insulated from these pressures by the underlying credit quality of our tenants, 67% of which are investment grade quality. Better yet, 90% of our investment-grade tenants have a credit rating of A minus or higher. This means that these tenants would need to be downgraded several times before they could potentially lose their investment-grade status. Our commitment to credit quality remains unmatched by our peers and we believe this strategy will pay dividends for our shareholders in any economic environment.
MOB same-store NOI growth was 1% during the quarter, our 20th consecutive quarter of positive same-store growth. Headline performance in the period was adversely affected by a unique situation at a single location in our portfolio.
Specifically, our asset management team was faced with a physician group tenant that had a reduced need for real estate and an in place plan to consolidate locations. We made the decision to move aggressively to retain at least part of their space in our building as a means of preserving the healthcare ecosystem of the asset, and we are already in discussions with several potential providers to lease space not renewed by this tenant. Overall, this asset represents less than 1% of the same-store pool.
Conversely, the 14 building landmark portfolio joined the same-store pool this quarter. As expected from such a high quality portfolio, occupancy is up 50 basis points since our acquisition and the portfolio grew cash NOI by 4.1% year-over-year. In total, the portfolio is exceeding our underwriting expectations and is representative of the quality facilities and tenant at the center of DOC's investment criteria.
First quarter renewal spreads were impacted by the same scenario I just discussed during our same-store commentary with headline spreads totaling negative 0.7%. Excluding this one asset, renewal spreads for the quarter were positive 10.1%.
In total, our leasing team completed 367,000 square feet of leasing activity this quarter including 289,000 square feet of lease renewals and a 72% retention rate. The great work this quarter by our leasing team to reprice lease renewals at today's fair market value with a 10.1% leasing spread should not be overlooked by one lease.
Additionally, this leasing activity offers strong compounding growth for the future as approximately 60% lease assigned this quarter contain annual rent escalations of 3% or more. Looking back to the 2018 to 2021 time period, only 25% of our leasing activity on average contained annual rent escalations of 3% or more.
Despite the short-term impact of a few vacancies in the portfolio, we believe the long-term value opportunity for our portfolio is fully intact as outpatient services drive retention and market pressures continue to increase triple net rental rates.
Our team is focused on unlocking the full value of our portfolio through aggressive leasing initiatives, exceptional property management and smart capital improvement investments.
Before turning the call back to JT and opening for questions, I'd like to quickly say congratulations to John Sweet, the Founder of DOC for earning the 2022 Lifetime Award from Healthcare Real Estate Insights. The award was presented in January at the Revista Medical Real Estate Investment Forum.
John has always been known by hospital executives, brokers, developers, and investors for his witty sense of humor, unwavering integrity, and creativity in structuring investment transactions. As we celebrate the company's 10th anniversary this July, we cannot be happier to honor John for his career and contributions to the medical office industry, and we recognize as mentorship and friendship to all of us at DOC. Congratulations, John.
With that, I'll turn the call back over to JT.
Thank you, Mark. Thank you, Jeff. We'll now take questions.
Thank you. We will now be conducting a question-and-answer session. [Operator Instructions]
And our first question comes from Austin Wurschmidt with KeyBanc Capital Markets Inc.
Hey, good morning, everybody. Guys you've spoken about sort of stable occupancy previously in the first half and headwinds abating in the back half of the year. But clearly there was an impact from this one tenant you highlighted in your prepared remarks. I'm just curious how that changes the cadence for occupancy comps in the first half and even back half the year relative to those prior expectations?
Hey, good morning Austin. Its Mark Theine. So, as I mentioned in the prepared remarks, our leasing statistics were outsized by this one tenant, but our portfolio we're really starting from a position of strength with industry leading 95% occupancy.
Over the history of our company, we've always been in that 95% occupancy range. So, we are experiencing a couple of one or two kind of moveouts and normal churn of the portfolio. But long-term, our occupancy has always been around 95%. We've been well served by our triple net leases, high occupancy, especially in this inflationary environment.
So, within the same-store pool, when do you think full occupancy you've said is 95%, 96%. When do you the same-store pool gets back to within that range?
Yes. So, again, we feel very confident in our comments about the improvements in the back half of the year. Really pointing to that, we do have 58,000 square feet of leases signed that are under construction and we expect rent commencement in the back half of the year. So, as those leases start to come on, we'll recognize them in our occupancy and obviously, our rent growth. So, that'll get us more in line with our expectations of the 2% to 3% same-store growth in the back half of the year.
Thanks for that. And then just last one for me on the investment pipeline, you highlighted that acquisitions have picked up since earlier this year. I'm just curious if you could put a finer point on sort of the size of that pipeline, where bid ask spreads are today, whether they've narrowed to a level that you think makes sense for you to transact?
Yes. Awesome. Thanks it's JT. It's still modest on the acquisition front. We do have some growing pipeline. There's some activity out in the market. There's still private buyers in particular in in the low sixes range, we'd like to be higher in the sixes and up into the seven cap rate, but without jeopardizing quality or the credit quality or the quality of the facility.
So, we'll see some activity pickup and we can expect more to come to market. Working with some health systems, looking at some potential monetizations there, So, we're excited about that. The real pipeline is on the development front and just working through kind of final documentation and pricing of those transactions.
Thanks John.
Our next question comes from Juan Sanabria, BMO Capital Markets.
Hi. Just hoping to expound on that last piece about the development funding. It seems like the deals you've done recently are in in the low sixes. Is that a good bogey for development capital, giving your comments about where traditional acquisitions are? How should we think about that development capital mentioned $300 million opportunities that going forward?
Yes, Juan, we -- those get price too well in advance of actual construction starts. And the Beaufort project has with the 3% bumps, the quality of the location. Our IRR on that facility is much closer to 8.5% to 9% So, we'd like it to be higher when we start on that particular, but it's still a fantastic project.
The second project is not priced and we would price it at a different rate today in the current market. At the time, we were negotiating through that and we'll be purchase acquisition rates for in the low 5. So, it's just -- it's obviously a timing thing with that and we're looking at different ways to think about that and the long-term commitments we make there.
So, development starts, the things we're negotiating now are in the high sixes, low sevens, from a current yield because most projects we do are on a -- kind of loan down or more of a construction loan project and those are in the high sixes to low sevens if we were pricing them today.
Great. And then just curious on any dispositions you guys have targeted. You had a kind of a small one done in in the first quarter? Any other opportunities? And if you can give us any color on the cap rate on that small piece that was sold off in the first quarter?
Yes, I'll speak about dispositions and ask Mark to give you some more specific details. We don't have a meaningful disposition strategy for this year. Opportunistically, we may sell a building here or there. We have we own 300 -- almost 300 buildings. So, there's always a handful in the in the portfolio that are older, smaller, in different markets where we're not strategically growing.
So, from time-to-time, we may strategically dispose of something, but nothing specific. No material plans. Mark, do you want about this?
Yes. Juan on the more specifics on just the one small asset we sold in the quarter was That building was originally acquired in the early life at DOC as part of a five building portfolio.
This is the one building that was not as strategic in the existing tenant in the building as if they could purchase the building from us. The cap rate on that was actually just below 4. But again, very small building and what's more representative of our disposition strategy is what we completed last year with Great Falls. We had an we had an amazing exit with a great partner there in Great Falls and redeployed that capital accretively.
Thanks guys.
Thanks Juan.
Our next question comes from Ronald Camden with Morgan Stanley.
Hi, this is Derrick Metzler on for Ron. Thanks for the question. So, curious about the one asset that dragged down same-store NOI. Could you provide any more color on the impact that it had given your comment that it was a relatively small asset?
Yes. This is Mark. I'll take that one again. So, start with the fact, again, this is our 20th consecutive quarter of same-positive same-store NOI growth. And we currently we don't have a redevelopment or repositioning bucket, we report on all of our properties.
So, as I mentioned last quarter, you know, we were expecting same-store to have a little bit slower start, but picking up in the back half of the year. And this one building in particular was a 110,000 square foot cancer center. We acquired in 2014 at a 7 cap and for nine years, they paid their rent on time every month. And we -- through our relationship with them, became aware of their plans to consolidate their office space and really reduce their square footage by about 50%.
Some of which was admin space, some of which is clinical space, but the direct impact from this one tenant on same-store this quarter is 73 basis points same-store. So, our one would have been 1.73 excluding this building, and it had a 30 basis point impact on our occupancy year-over-year.
So, just to help kind of contextualize this a little bit more, $200,000 in our same-store pool out of $82 million of cash NOI moves same-store 25 basis points. So, it doesn't take a lot of cash flow to really move same-store percentage quarter-over-quarter.
So, again, what I said before, what gives us confidence in the back half of the year is the lease assigned that are under construction and we'll commence in the back half of the year.
Our target for increasing our occupancy there is really our investment-grade hospital systems that are existing in the buildings and we're working closer with them to continue to expand.
Understood. I appreciate that. I guess the follow-up is have you identified any more tenants that are potentially at risk for reducing their space similarly?
No. Nothing, nothing to this size.
Great. Thank you.
Our next question comes from Michael Carroll with RBC Capital Markets.
Yes. Thanks. JT, I wanted to touch on the private investment market. I know last quarter you highlighted that cap rates were in the mid-sixes trending upwards towards 7. But today, you highlighted that the private market bid is aggressive and maybe those cap rates are in the low 6 today. Are you surprised by the strong private bid and how it has not changed as quickly as you would have expected?
Yes. It's really trying to understand how that is -- how they're making the math work on those projects and talking to some of those private buyers. They have some all equity with low returned expectations. There's not a lot of bank financing. I wouldn't say there's high volume of those transactions, but there are people out in the market kind of high fives, low sixes.
So, I don't think that's reflective of what the current value is. It's more of a reflection of people with buckets of capital, they're willing to take a bet that interest rates decline next year and cap rates go back to the 5s. I think that's kind of the simple math they're doing.
We are active acquisition pipeline. It's in the high 6s as low 7s. We don't have a lot of volume in those numbers, but we do have good discussions in place.
Okay. So, it's your active pipeline right now. You do have sellers that are contemplating on selling at those at those high 6 levels?
Yes.
Okay. And then on the Northside development, when was that agreement reached? I guess, I was surprised that that cap rate was fairly low. I mean, even at that cap rate, is it accretive to you? Or are you guys -- is that deal kind of expecting that you need interest rates to drop for that to kind of drive some accretion?
No. We the -- it's got 3% bumps. Again, about half the equity is coming from the physicians that are leasing the building. They've already written those checks. So, we've got this advanced funding from last year. It's really early of last year mid spring kind of discussion around the pricing at the time, 6.2% was much higher than acquisition cap rates and time. So, we -- again, the development is not a spot financing production. So, it's -- we were pricing it today. It would be higher.
Our long-term IRR on that project, Mike, is still in the mid 8% to 9% and that's without executing another transaction changing cap rates or interest rates in the future. So, we feel good about it. We'd price it higher today if we could, but we're still going to make money on the project.
Okay. And then why did you like to do that project on an on-balance sheet development. I know historically you've been more doing these construction loans. So, I guess why is that project different?
There's some unique circumstances with Northside and its location. They own the land. So it's on our ground lease. They have they have the second building's already designed and we think there's leasing demand to move forward with that project in the next year and that one will price again based upon kind of current pricing at the time. But and it would be priced differently if we were starting it today.
But it's worth that ask for us to build it on balance sheet again for some unique circumstances. The tenant base is partly their employees, partly affiliated positions that aren't employed by them. A combination of, health care compliance and Northside their own balance sheet management. So we're excited to do it.
We're working with RTG as the developer on that project to we who we partnered with before. They do a great job and have done a great job getting the billing to a 100% pre-leasing before we started funding it.
Okay. So then this is more of a unique situation. We shouldn't expect future ground up development fund balance sheet?
I think you I think you'll see some, but our preference is the loan down where we're getting current construction loan yield and have more optionality on the back end to -- on the -- on potential of an acquisition. But you may see it from time to time. But, we're excited to do it and expand our relationship. It's a great market. Atlanta is still, very high.
Okay. Great. Thank you.
Our next question comes from Michael Griffin with Citi.
Great. Thanks. Maybe to start off with the capital allocation kind of strategy high level, piggybacking off the previous Mike's question. I think you've talked about in the past about, solid balance sheet, a strategy for outsized growth. I mean, I'm curious maybe if you can elaborate JT on where this growth is coming from, And probably the capital question for Jeff, why put capital out today? Would joint ventures make sense? You talked about the development funding a minute ago. So any commentary on that would be helpful?
Yes. You know, beginning in the fourth quarter of last year, as interest rates were, you know, rising dramatically and fast and cap rates on acquisitions was not keeping up with that and still hasn't really reached equilibrium. We've been very modest on acquisitions.
Not even a lot of builders trying to continue discussions we've walked away from opportunities where they were very attractive 18 months ago that aren't attractive or aren't as attractive today. Many sellers are just holding firm and hoping that interest rates decline and the cap rates improve from their perspectives next year.
So we don't expect a lot of acquisition opportunity this year. The development pipeline, again, those are usually two years of construction projects and we can get outsized deals there. But you do take some capital risk and you do take some modest development risk, which we don't think we're taking any there because of the getting to 100 percent pre-leasing with investment grade quality tenants like the Northside project.
So, I think those are mitigate over time that $300 million pipeline we're talking about, much of which won't even price or get started into a later in the year. So, again, it's a balance and forward looking projection if best we can about how to, how to price those projects. Jeff?
Yes. A little bit on the capital side. So, obviously, we reduced our leverage a little bit in the face of rising interest rates. And to try to build up some capacity in dry powder to take advantage of acquisitions and development opportunities. So we, we issued some stock around $15 per share. So that's kind of a, it's called 6.4% 6.5% implied cap rate. We feel confident that when we -- we redeploy those proceeds, we'll be getting, yields in excess of that.
So I think we can we can utilize the capital that we raised accretively in the back half of the year. And again as JT has talked about, it's a little bit market dependent. On how fast we can get that out the door. But we feel like we're in a good position to do so.
Thanks for that, Jeff. I appreciate the additional disclosure on the release about the ATM issuance. I double checked with the prior quarter one, and so it wasn't any new news. So appreciate that. And then maybe one for Mark, just on the leasing side of thing. I think the lease percentage ticked down a little bit in the quarter, but it's still pretty high at around 95%. How are you kind of incorporating this into expectations around leasing occupancy growth this year and the ultimate impact on same-store? Thank you.
Yes. Definitely. Take that. So on leasing as you just mentioned. And, again, we're starting 95% occupancy. So full -- but one thing we're doing -- actually two things we're doing a little differently right now. One is we're more proactively investing CapEx dollars into some of the vacancies.
To make sure that spaces are ready available for lease immediately, but we're not, caught with supply chain challenges, anything like that. So we're being very proactive with our CapEx dollars to have spaces that are show ready.
And then second, our leasing team this year has done a great job and it mentions on the first last earnings call that we've really increased our online marketing efforts and our broker outreach to enhance communication and really market those vacancies online and with some new virtual reality technology and online tours. So it's definitely a focus of our entire team to improve occupancy throughout the year.
Great. Thanks. That's it for me. And as an Atlanta native, just wanted to say I have to check out the new properties next time I'm back in my back there. Thanks.
Yes. We'd love to take you for a tour.
Our next question comes from John Pawlowski with Green Street.
Hey. Good morning. Thanks for the time. I know you talked touched on the landmark portfolio briefly in your prepared remarks. So I apologize I missed this data point, but could you quantify what type of lift the Landmark portfolio had on the same-store NOI growth in the quarter?
Hey, John. This is Mark again. So first, welcome to the DOC call. Great to have you here. We appreciate the support from Green Street. Landmark, it's -- about 1.4 million square feet out of our 15 million square foot, 50.2 million square foot same store portfolio. So, while great results there just based upon the, overall size of the same store portfolio, it doesn't have outsized impact on our same store results. But those properties alone right there, 4.1% from the same store is a result of some increased occupancy and done a really good job. The landmark portfolio itself is 11% percent of the same store pool so year over year again, 4.1% percent growth there.
Okay. So I know, a portfolio, there's always it is, so graphic moving pieces. But instead they exclude the one property that had a large decline and renewal spreads, it sounds like that was a 70 bps drag, but landmark was a positive. So it feels like if you exclude those two pieces, the rest of the same store is kind of stuck in the low 1% analog NOI growth range. So if you looked through the portfolio. Is there any other concerning trends that's best to take a while longer to get back to that historical growth profile?
Yes, John. So the one thing I would add to what you just said, you're starting to build on it correctly with the excluding Zingmister [ph]. But the one thing I'd add is, again, is the 58,000 square feet of leases that are already signed and under construction. Once those come online on a run rate basis, they'll add to approximately $400,000 of NOI a quarter.
So that will continue to help build our same store and that could be another 40, 50 basis points there just from leases that are already signed. So again, that's on a run rate basis. They'll come online throughout the -- the back half of the year, not all at the same time, obviously, but throughout the back half of the year. And, that's what gives us confidence that we'll be rebounding into our more historical range of 2% to 3%.
Okay. Last one for me, just on the development app test development. And so I understand the lag at when deals are priced versus when you're actually committing capital. Just curious, John, why not walk away or re-price the economics of the $41 million construction start if the world changes Just curious why you're kind of anchoring the pricing a year ago?
Yes. John, there's we have a core value called CARE, where we collaborate, communicate, act with their integrity. We respect the relationships and we execute consistently. We've built this company for 10 years by being reliable with our health partners and we do re-price. We have re-priced where we have the opportunity.
Again, we are in the I8 on an IRR basis on this transaction, 6.2 is the first year yield that grows 3% a year within, primarily an investment grade health system, and we'll have the opportunity to expand this campus by another 100,000 feet in the near future.
So we don't see it as a as a project you walk away from. We see as a project you work with your partner and get to the finish line where you can. Other projects we've done exactly what you suggested. We've walked away from purchase options that again where we have the optionality and that's kind of the preferential way we like to do the development projects. So each situation, stands on its own merits and circumstances.
All right. Thanks for the time. I appreciate it.
Our next question comes from Mike Miller with JPMorgan.
Yes. Hi. Just a quick one. On the construction loan, the $35 million construction loan, looks like that's tied to a project with a renovation attached to it for surgery center, and it looks like you're planning to take that out in the back half of the year. What's the cost of that that you'll be acquiring, and then does that effectively just kind a come out of the loan balance? Is that the way to think of it?
No, it's a small part of the total project. The ASC, which is the first step of the redevelopment of that location with Emery is it's cap rates in the high. It's been closer to an eight, but we're committing capital to redevelop that. So, ultimate yield on that's in the sevens. And then the construction project is a separate loan, and then it's priced at 6.75% 6.8%.
And then we have optionality whether to purchase that building on the back end and we'll evaluate to John's point a minute ago, evaluate the value of that purchase option at the time of execution or walk away from it or try to reprice it.
So it's a small piece, the ASC piece. It's nice yielding with a small $4 million or $5 million acquisition, and then we've committed capital to renovate and improve that billing.
Got it. Okay. It clears it up. Appreciate it. Thank you.
Our next question comes from Tayo Okusanya with Credit Suisse.
Hi. Yes. Good morning, everyone. In regards to the space, you guys are kind of strategically holding back for the kind of "right tenant". Could you just kind of talk us through a little bit about kind of what that total square footage is? What kind of rents you're ultimately kind of expecting on that space? And kind of earnings contribution once all that kind of leased up and kind of what's the internal timing around or internal targets around some of that stuff?
Hey, Tayo. One clarification, you said, you know, kind a holding out or non-renewal space to hold out for a better tenant. That's really not exactly what we do. In non-renewal space because we have a better tenant in hand. And that's the perfect example is the 55,000 square feet of leases that are under construction. So it just takes a period of time to build out that space for the incoming tenant.
And we don't count that as least, occupied space until the rent commences, as appropriate accounting. And that particular location are those 55,000 feet. Is 50 bps of same store?
Yes. Just 100.
Yes. Yes. So pretty meaningful contribution. And gets us back to 95% actual lease space when those commence. On the building that where we had to repositioning this quarter. We already have an active lease pipeline. Again, those discussions have been in place for a while. Amy Hall and her team have done a great job of building a list of tenants to backfill and lease that space at market rates. And we think that building get back to kind of high occupancy in second half of this year or first half of next year. So it'll start contributing again momentarily.
Okay. And then just like target economics for the, I mean, when you're going to release the space, are you -- is the goal you want in 10%, 20% spreads on kind a what the old leases look like? Or just trying to get a general sense of what kind of economic at targeting.
Yes, Tayo. So I think you're making a great point here, which is that our vacancy and short term leases really have an opportunity right now to increase cash flow as we're in an environment where rental rates are increasing quickly. In fact, just yesterday, just as a as an example, we were shared a leasing flyer for our brand new development in Texas and our second largest market. It's not an investment that development deal that we're directly involved with, but it's located right next to a large existing building we own.
And the development rental rates and in that leasing flyer were 40% higher than the rents we have in place in our existing building that was built five years ago. So similar, you know, quality, even larger building a large delta between what current construction rental rates asking rental rates are and where are they embedded in rental rates of our portfolio are.
So there's a great opportunity. And that's where our leasing team, our asset management team is focused on, is really understanding each market and bringing those current leases mark to market.
As I said, I absent the one lease we discussed. We had 10.1% leasing spreads this quarter, which is a phenomenal job by our entire leasing team. And great potential with our asset management team.
Great. Thank you.
Thanks, Tayo.
Our next question comes from Josh Dennerlein with Bank of America.
Yes. Hey, guys. Thanks for the time. Just kind a wanted to ask about something you mentioned in the opening remarks. I think I heard correctly, you mentioned you expect the transaction activity to pick up in the second half of this year. What's driving that your expected -- that expected pickup?
Yes. I think the just knowing what's in our pipeline and discussions, again, when we don't do much at all, any new acquisition is a pickup, right? So -- but we do have some active discussions, but it's not the kind of volumes we've done historically, because we're really pushing long-term cost of capital and trying to match up with market first year yields.
So but I do think the market generally there's a lot of loans -- IO loans that were issued in 2019, 2020 that were attached to buildings that were purchased at 4.5%, 5% yields. And those loans are now costing 7%, 7. 5%. So it's -- there's a mismatch there, negative leverage acquisitions to cash flow, the LTVs are not -- don't support the size of those loans.
So we're starting to see -- it's small right now, but I think that activity will pick up where we see not distressed buildings, but owners who don't want to come out of pocket to support that kind of cash flow. So we think there's a pretty large volume of that kind of opportunity out there. We'll see if it materializes or not if interest rates fall, maybe people, kind of ride it through until till the future. But right now, we're starting to see some evidence of those kind of that kind of combination coming to fruition.
Interesting. Are those mostly like one-off assets or are they more, like, portfolio of size.
Yes. I'd say a combination. But one-off assets is primarily what we look at. It's rare that we do. We've done two very large portfolios, but we've really built the company one building at a time so.
All right. Thank you.
Yes.
Our next question comes from Steven Valiquette with Barclays.
Great. Thanks. Good morning. You touched on this a little bit, but I guess I was kind a curious too just on the for the same store NOI numbers. I think this is like the maybe the fifth quarter in a row where the expense growth was faster than the revenue growth. And I was wondering if there's just a line of sight to when that might reverse when the same-store revs would maybe ideally be growing faster than the expense line.
You talked about the part of the remedy on that, but I'm curious if there's any other one. If it's contingent just upon that additional leasing you talked about or just other factors as well maybe controlling expenses there. Just more color on that would be helpful. Thanks.
Yes, Steve. So operating expenses in the same-store pool were up 6.9% year-over-year sort of in line with some recent inflation for this. We're coming off of a period last year where this comparable operating expenses were really flat in the comparable period, but prior a year ago.
And if you if you look a little deeper into that, what we're seeing on operating expense growth is number one utilities, not necessarily consumption because we made some very intelligent and wise capital investments in the building. But in the rate of utilities, we're seeing a pretty large increase. And then we're also seeing some increases in labor related to janitorial engineering, things like that. So year-over-year, that's where the operating expense growth is.
But again, one of the benefits of our highly occupied triple net lease portfolio is that those operating expenses are nearly offset in our recoveries which are baked into that rental revenue line item there as well. So our asset management team, property management team are always focused on keeping total occupants see cost low, managing operating expense as well and leveraging economies of scale. But we'll continue to try and focus on keeping those operating expenses below the inflation line.
Got it. Okay. Appreciate the color. Thanks.
We are closing our question-and-answer session. Now, I would like to turn the floor back over to John Thomas for closing comments. Please go ahead.
Thanks again everybody for joining us today. We look forward to me seeing you at NAREIT and future investment conferences and speaking to you again in August. Thanks.
This concludes today's conference call. You may now disconnect your lines. Thank you for your participation, and have a great day.